Loading...
NPI 1639621659 · Greenville, SC · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Luxor Scientific, LLC is a clinical medical laboratory provider located in Greenville, South Carolina. This profile covers 90 Medicare and 132 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Luxor Scientific, LLC |
| Address | 1327 Miller Rd Ste F |
| City | Greenville |
| State | SC |
| ZIP | 29607 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | October 25, 2016 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $5.6M |
| Medicare | $2.2M |
LUXOR SCIENTIFIC, LLC’s billings are heavily concentrated in definitive toxicology and high-throughput drug-screening services: Medicare receipts show major contributions from G0482 ($975.6K) and G0483 ($845.3K), while Medicaid receipts are dominated by G0483 ($2.4M) and G0482 ($1.2M). The presence of large claim volumes for instrumented presumptive screens (80307: Medicaid 23.1K claims, $508.1K revenue) alongside definitive LC/MS–type codes indicates an operational focus on both screening and confirmatory drug testing workflows rather than exclusively routine clinical chemistry panels.
Revenue concentration is extreme in both payers: the provider’s top three Medicare codes account for 89.6% of its total Medicare revenue, and the top three Medicaid codes account for 80.9% of its total Medicaid revenue. This level of concentration signals reliance on a narrow set of toxicology-related service lines for the bulk of billed revenue.
The payer mix is Medicaid‑weighted: lifetime Medicaid revenue is $5.6M versus total Medicare revenue of $2.2M, so Medicaid is the larger revenue source for this provider. Analysts should treat state Medicaid reimbursement trends and contracts as the primary commercial lever for this entity’s financial performance.
On Medicare, LUXOR is a national high‑volume participant for its top definitive testing code: G0482 generated $975.6K, 5K claims and ranks #8 of 1618 providers nationally (100th percentile; notably above typical national volume for this code), and G0483 produced $845.3K and ranks #25 of 1063 providers (98th percentile). These rankings position the provider as a major national supplier for select definitive toxicology panels rather than a marginal local lab.
Within South Carolina Medicaid, the provider is a leading in‑state supplier for its core toxicology services: G0482 ranks #1 of 7 providers in-state (100th percentile; notably above typical state volume) and G0483 ranks #2 of 8 providers in-state (86th percentile). High state claim counts for 80307 (23.1K claims, $508.1K revenue; ranks #5 of 156, 97th percentile; notably above typical state volume) further reinforce a strong in‑state market position for both presumptive and confirmatory testing.
The NPI was enumerated on 2016-10-25 (~10 years ago), indicating about a decade of billing history in public payer data. That tenure is long enough to observe established billing patterns centered on toxicology services rather than a transient or start‑up billing profile.
Outside of toxicology, the provider bills a range of routine clinical tests at much smaller dollar volumes: Medicare line items include 80053 ($11.6K), 84443 ($10.6K), and 82306 ($5.2K), and Medicaid includes 80061 ($24.7K) and 82306 ($35.3K). These ancillary clinical chemistry and endocrine tests suggest capability to perform standard laboratory panels, but they represent a minor portion of total revenue compared with drug‑testing codes.
Statistical descriptors in the source data support a mixed pattern of outlier performance and typical volumes: several toxicology codes are labeled "notably above typical" or in top percentiles nationally and in‑state (e.g., G0482 national 100th percentile; G0482 in-state 100th percentile), while many other CPT codes are described as "typical, unremarkable volume." This indicates the provider’s market strength is concentrated in a few high‑volume toxicology offerings while other services align with normal peer activity.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
90 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 5,030 | $190 | $975.6K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3,490 | $240 | $845.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2,110 | $60 | $128.9K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 550 | $110 | $61.4K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 150 | $150 | $23.1K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 480 | $30 | $16.5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,160 | $10 | $11.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 670 | $20 | $10.6K |
| 82670 | The lab analyst measures the level of total estradiol, an estrogenic hormone, on a specimen such as blood using a method such as liquid chromatography–tandem mass spectrometry (LC–MS/MS) to evaluate… | 370 | $30 | $9.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 1,170 | $10 | $9.4K |
Showing 1–10 of 90
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 90 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
90 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0482 | 1 | 10 | 110 | $190 | $210.1K |
| G0483 | 1 | 10 | 160 | $240 | $162K |
| U0004 | 4 | 10 | 150 | $70 | $136.4K |
| 88305 | 233 | 240 | 620 | $30 | $50.2K |
| U0005 | 7 | 10 | 320 | $20 | $43.1K |
| G0481 | 19 | 40 | 150 | $150 | $35.2K |
| 87186 | 5 | 10 | 1,440 | $10 | $32.7K |
| 87088 | 5 | 10 | 1,270 | $10 | $25.7K |
| 80307 | 1 | 130 | 110 | $60 | $14.6K |
| G0480 | 1 | 50 | 90 | $110 | $13.8K |
Showing 1–10 of 90
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
132 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 25,790 | $90 | $2.4M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20,310 | $60 | $1.2M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 23,100 | $20 | $508.1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 8,130 | $50 | $398.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 1,200 | $90 | $102.9K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,700 | $40 | $66.5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 650 | $100 | $64.6K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 2,720 | $10 | $35.3K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 1,360 | $20 | $31.2K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 390 | $70 | $26.6K |
Showing 1–10 of 132
How this provider's Medicaid billing volume and revenue compare to other South Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. South Carolina median
132 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2 | 10 | 13,730 | $90 | $1.2M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 88 | 210 | 1,470 | $60 | $615K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 10 | 1,330 | $60 | $349.1K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 139 | 150 | 2,500 | $50 | $324.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 128 | 710 | 350 | $60 | $247.2K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 14 | 50 | 170 | $60 | $206K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 50 | 120 | 1,100 | $30 | $170.4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 10 | 20 | 990 | $80 | $159.1K |
| 81001 | Urinalysis is used to detect substances or cellular material in the urine associated with different metabolic and kidney disorders. It is used to detect urinary tract infections (UTI) and other… | 148 | 180 | 1,360 | $20 | $152.1K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 5 | 10 | 150 | $10 | $144K |
Showing 1–10 of 132
Other providers in the same ZIP code as Luxor Scientific, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.